ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares fell -3.30% in last trading session and ended the day at $19.65. ACAD has a return on assets of -63.00%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) quarterly performance is -39.54%.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data included in ACADIA’s New Drug Application (NDA) for NUPLAZID™ (pimavanserin) for the treatment of psychosis associated with Parkinson’s disease. The Advisory Committee Meeting is scheduled for March 29, 2016.
Exxon Mobil Corporation (NYSE:XOM) is now the first major fuel retailer to accept mobile payment at the pump, including Apple Pay, throughout the majority of its U.S. network. The Speedpass+ mobile payment app is now available at more than 6,000 Exxon- and Mobil-branded retail stations across the U.S.
Exxon Mobil Corporation (NYSE:XOM) ended the last trading day at $82.82. Company weekly volatility is calculated as 1.92% and price to cash ratio as 92.83. Exxon Mobil Corporation (NYSE:XOM) showed a weekly performance of 0.23%.
On 15 March, ServiceNow, Inc. (NYSE:NOW) shares fell -1.12% and was closed at $61.65. ServiceNow, Inc. (NYSE:NOW) year to date (YTD) performance is -28.78%.
On 9 March, ServiceNow, Inc. (NYSE:NOW) has settled its patent row with Hewlett-Packard. The financial details of the settlement were not disclosed. The agreement resolves all claims asserted by Hewlett-Packard.
Concurrent Computer Corporation (NASDAQ:CCUR) shares fell -1.39% in last trading session and ended the day at $6.38. CCUR Gross Margin is 59.30% and its has a return on assets of 4.20%. Concurrent Computer Corporation (NASDAQ:CCUR) quarterly performance is 32.92%.
Concurrent Computer Corporation (NASDAQ:CCUR) announced a cash dividend payment of $0.12 per share is scheduled to be paid on March 29, 2016. Shareholders who purchased CCUR prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 12th quarter that CCUR has paid the same dividend.
INSYS Therapeutics, Inc. (NASDAQ:INSY) caters to the Healthcare space. It has a net profit margin of 17.70% and weekly performance is 6.37%. On the last day of trading company shares ended up at $17.71. INSYS Therapeutics, Inc. (NASDAQ:INSY) distance from 50-day simple moving average (SMA50) is 16.36%.
INSYS Therapeutics, Inc. (NASDAQ:INSY) announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) declined to institute an inter partes review of U.S. Patent Nos. 8,486,972, 8,835,459 and 8,835,460, which cover the fentanyl formulation of SUBSYS® (fentanyl sublingual spray).
Leave a Reply